CDKN2B-AS1 and neoplasm: In addition, ANRIL promotes tumor cell proliferation by regulating target genes in trans. ANRIL promotes the epigenetically silencing of miR-99A/miR-449A, therefore upregulating mechanistic target of rapamycin and cyclin-dependent kinase 6/E2F transcription factor 1 pathways (129).